asa glp 1 GLP-1-based meds linked to fewer heart events in adults with obesity, autoimmune disease ASA Advises No Longer Holding

Another is a White House agreement with Novo Nordisk and Eli Lilly to cap GLP-1 prices at no more than $350 a month, including for Medicare and Medicaid beneficiaries

They also help explain why only about one-third to half of people remain on GLP-1s after a year, with cost likely playing a role as well

Jo-1 (Histidyl-tRNA Synthetase) : This marker is linked to a condition called polymyositis, which causes muscle inflammation

And since the May 2025 deadline has already passed, healthcare professionals recommend acting now rather than waiting until your supply runs out

Cagrilintide Semaglutide might be a great option especially if youve struggled to get results with other treatments